Early Mechanistic Events Induced by Low Molecular Weight Polycyclic Aromatic Hydrocarbons in Mouse Lung Epithelial Cells: A Role for Eicosanoid Signaling.
Alveolar Epithelial Cells
/ drug effects
Animals
Anthracenes
/ chemistry
Cell Line
Cyclooxygenase 2
/ metabolism
Eicosanoids
/ metabolism
Enzyme Activation
Fluorenes
/ chemistry
Group IV Phospholipases A2
/ metabolism
Metabolomics
Mice, Inbred BALB C
Molecular Weight
Phosphorylation
Signal Transduction
/ drug effects
Time Factors
Up-Regulation
p38 Mitogen-Activated Protein Kinases
/ metabolism
eicosanoids
lung
metabolomics
p38 MAPK/cPLA2
polycyclic aromatic hydrocarbons
secondhand smoke
Journal
Toxicological sciences : an official journal of the Society of Toxicology
ISSN: 1096-0929
Titre abrégé: Toxicol Sci
Pays: United States
ID NLM: 9805461
Informations de publication
Date de publication:
01 05 2019
01 05 2019
Historique:
pubmed:
29
1
2019
medline:
21
4
2020
entrez:
29
1
2019
Statut:
ppublish
Résumé
Low molecular weight polycyclic aromatic hydrocarbons (LMW PAHs; < 206.3 g/mol) are under regulated environmental contaminants (eg, secondhand smoke) that lead to gap junction dysregulation, p38 MAPK activation, and increased mRNA production of inflammatory mediators, such as cytokines and cyclooxygenase (COX2), in lung epithelial cells. However, the early mechanisms involving lipid signaling through the arachidonic acid pathway and subsequent eicosanoid production leading to these downstream events are not known. Common human exposures are to mixtures of LMW PAHs, thus C10 cells (a mouse lung epithelial cell line) were exposed to a representative binary PAH mixture, 1-methylanthracene (1-MeA) and fluoranthene (Flthn), for 30 min-24 h with and without p38 and cytosolic phospholipase A2 (cPLA2) inhibitors. Cytosolic phospholipase A2 inhibition reversed PAH-induced phospho-p38 MAPK activation and gap junction dysregulation at 30 min. A significant biphasic increase in cPLA2 protein was observed at 30 min, 2, and 4 h, as well as COX2 protein at 2 and 8 h. Untargeted metabolomics demonstrated a similar trend with significantly changing metabolites at 30 min and 4 h of exposure relative to 1 h; a "cPLA2-like" subset of metabolites within the biphasic response were predominately phospholipids. Targeted metabolomics showed several eicosanoids (eg, prostaglandin D2 (PGD2), PGE2α) were significantly increased at 4, 8, and 12 h following exposure to the binary PAH mixture and this effect was p38-dependent. Finally, PAH metabolism was not observed until after 8 h. These results indicate an early lipid signaling mechanism of LMW PAH toxicity in lung epithelial cells due to parent PAH compounds.
Identifiants
pubmed: 30690640
pii: 5303346
doi: 10.1093/toxsci/kfz030
pmc: PMC6484882
doi:
Substances chimiques
Anthracenes
0
Eicosanoids
0
Fluorenes
0
fluoranthene
360UOL779Z
1-methylanthracene
610-48-0
Ptgs2 protein, mouse
EC 1.14.99.-
Cyclooxygenase 2
EC 1.14.99.1
p38 Mitogen-Activated Protein Kinases
EC 2.7.11.24
Group IV Phospholipases A2
EC 3.1.1.4
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
180-193Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL123385
Pays : United States
Organisme : NIEHS NIH HHS
ID : R15 ES024893
Pays : United States
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Bioinformatics. 2014 Jan 1;30(1):133-4
pubmed: 24174567
J Chromatogr A. 2012 Sep 7;1254:43-50
pubmed: 22835696
Transl Res. 2010 Feb;155(2):57-61
pubmed: 20129485
BMC Bioinformatics. 2010 Nov 23;11:571
pubmed: 21092268
Nature. 2014 Mar 13;507(7491):190-4
pubmed: 24499815
J Leukoc Biol. 1997 Jul;62(1):126-32
pubmed: 9226003
Toxicol Sci. 2018 Nov 1;166(1):51-64
pubmed: 30010986
J Lipid Res. 2015 Aug;56(8):1386-402
pubmed: 25838312
Curr Protoc Toxicol. 2011 Feb;Chapter 2:Unit2.18
pubmed: 21400682
Hum Exp Toxicol. 2018 Jul;37(7):752-761
pubmed: 29019276
J Appl Toxicol. 2013 Dec;33(12):1365-83
pubmed: 23722930
PLoS One. 2012;7(12):e53817
pubmed: 23285300
PLoS One. 2013 Jun 03;8(6):e65150
pubmed: 23755184
PLoS One. 2017 May 24;12(5):e0177595
pubmed: 28542572
Am J Respir Cell Mol Biol. 2006 Jan;34(1):28-38
pubmed: 16166744
Sci Rep. 2016 Aug 16;6:31424
pubmed: 27526857
Biochem Pharmacol. 2008 Feb 1;75(3):668-76
pubmed: 17981262
SAR QSAR Environ Res. 2006 Dec;17(6):597-605
pubmed: 17162389
Chem Res Toxicol. 2008 Feb;21(2):494-502
pubmed: 18062674
Arch Toxicol. 2018 Mar;92(3):1311-1322
pubmed: 29170806
Metabolomics. 2007 Sep;3(3):211-221
pubmed: 24039616
J Biol Chem. 2016 Mar 25;291(13):7070-86
pubmed: 26841868
Nat Rev Immunol. 2015 Aug;15(8):511-23
pubmed: 26139350
BMC Bioinformatics. 2010 Feb 18;11:94
pubmed: 20167110
Arterioscler Thromb Vasc Biol. 2011 May;31(5):986-1000
pubmed: 21508345
Anticancer Res. 1998 Mar-Apr;18(2A):775-82
pubmed: 9615719
Anticancer Res. 2006 Jul-Aug;26(4B):2857-61
pubmed: 16886605
J Vis Exp. 2014 Jul 11;(89):
pubmed: 25045913
Rep Carcinog. 2002;10:201-4
pubmed: 15334715
Environ Health Perspect. 1998 Aug;106 Suppl 4:975-81
pubmed: 9703481
Carcinogenesis. 2015 Jun;36 Suppl 1:S2-18
pubmed: 26106139
Eur Respir J. 2008 Jan;31(1):62-9
pubmed: 17959643
J Chromatogr A. 2013 Jul 26;1300:217-26
pubmed: 23672979
Am J Physiol. 1993 May;264(5 Pt 1):C1219-30
pubmed: 7684560
Environ Toxicol Chem. 2007 Nov;26(11):2308-16
pubmed: 17941746
Exp Lung Res. 2001 Apr-May;27(3):197-216
pubmed: 11293324
Mol Endocrinol. 2010 May;24(5):953-68
pubmed: 20211985
Cancer Res. 2004 Aug 15;64(16):5897-904
pubmed: 15313935
Cell Biol Int Rep. 1989 Sep;13(9):729-38
pubmed: 2680110
J Inflamm Res. 2015 Sep 30;8:181-92
pubmed: 26457057
Cancer Sci. 2008 Apr;99(4):696-705
pubmed: 18377422
Cell Res. 2005 Jan;15(1):11-8
pubmed: 15686620
Pharmacol Rep. 2016 Apr;68(2):319-28
pubmed: 26922534
IARC Monogr Eval Carcinog Risks Hum. 2010;92:1-853
pubmed: 21141735
J Immunol. 2017 Jun 15;198(12):4738-4752
pubmed: 28500069
FASEB J. 2002 Sep;16(11):1463-4
pubmed: 12205049
J Biol Chem. 1997 Jun 6;272(23):14501-4
pubmed: 9169405
SAR QSAR Environ Res. 2008 Apr-Jun;19(3-4):351-73
pubmed: 18637284
Carcinogenesis. 2004 Aug;25(8):1517-24
pubmed: 15033900
Nat Med. 2012 Apr 15;18(5):759-65
pubmed: 22504485
Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G673-81
pubmed: 17640974
Carcinogenesis. 1998 Jan;19(1):61-7
pubmed: 9472694
Toxicol Sci. 2017 May 1;157(1):156-171
pubmed: 28329830
Chemosphere. 2011 Jan;82(3):477-82
pubmed: 20947129
Toxicol Lett. 2011 Oct 10;206(2):121-9
pubmed: 21745554
Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):920-7
pubmed: 15184247
Cancer Lett. 1993 Jul 30;71(1-3):11-8
pubmed: 8395972
Environ Pollut. 2018 Mar;234:572-580
pubmed: 29223814
Toxicology. 1997 Nov 21;123(1-2):53-100
pubmed: 9347924
Pharmacol Ther. 2016 Aug;164:105-19
pubmed: 27126473
Carcinogenesis. 2005 Jul;26(7):1196-206
pubmed: 15746162